VP, Sales Execution
Mr. Wellinghoff joined the Company as Vice President of Sales Execution. He brings 25 years of experience in sales, sales management, and executive leadership building and leading organizations through the successful launch of products in cardiovascular and critical care medicine. Most recently he served as the Chief Commercial Officer at La Jolla Pharmaceuticals where he led marketing, sales, insights, and sales training surrounding the successful growth of Giapreza (angiotensin II). Prior to La Jolla, he was the Executive Vice President of Mainstreet Health where he led the launch of a transformative post-acute care model across the U.S.. Before joining Mainstreet, he spent 15 years at The Medicines Company in positions of increasing responsibility culminating with his role as Senior Vice President, Americas leading the continued success of their flagship product Bivalirudin and multiple product launches extending across various therapeutic areas. He began his career in the pharmaceutical industry as a representative at Bristol-Myers Squibb where he was recognized as a top performer in the Neuroscience & Infectious Disease division. Mr. Wellinghoff holds a BA from Florida State University.